Pharmaceutical Product Updates

 

CISplatin DHCP Letter - August 30, 2023

Temporary Importation of CISplatin Injection to Address Drug Shortage Frequently Asked Questions

---

Fresenius Kabi USA Vecuronium Bromide US Recall Packet – January 19, 2018

 

Fresenius Kabi USA Vecuronium Bromide Noncontinugous US Recall Packet – January 19, 2018

 

---

IV Solutions DHP Letter – November 17, 2017

---

Glycophos DHP Letter – November 6, 2017

Glycophos FAQ – November 2, 2017

---

Midazolam Injection Recall Packet US – October 30, 2017

Midazolam Injection Recall Packet Noncontiguous US – October 30, 2017

---

Sodium Phosphates IMPORTANT CORRECTION OF DRUG INFORMATION Letter – August 30, 2017

---

Fluphenazine Decanoate Injection Drug Recall Letter – March 16, 2017

Fluphenazine Decanoate Injection Drug Recall Letter – March 16, 2017 For customers located in Alaska, Hawaii and Puerto Rico ONLY

---

Midazolam Hydrochloride Injection Drug Recall Letter – December 16, 2016

Midazolam Hydrochloride Injection Drug Recall Letter – December 16, 2016 For customers located in Alaska, Hawaii and Puerto Rico ONLY

---

Xylocaine & Sensorcaine with Epinephrine Important Drug Information Letter - November 14, 2016

---

Bleomycin for Injection Important Drug Information Letter - June 15, 2016

---

Cisatracurium Besylate Injection Recall Letter - April 5, 2016

Cisatracurium Besylate Injection Recall Letter - April 5, 2016 For customers located in Alaska, Hawaii and Puerto Rico ONLY

---

Lidocaine Customer Letter - October 19, 2015

---

Calcium Gluconate Injection, USP Customer Letter - April 2015

---

Scopolamine Hydrobromide Injection, USP Supply Letter - February 2015

---

Vasopressin Injection, USP Customer Letter - February 2015

---

Midazolam Added to Controlled-Distribution Program - August 2013

---

Voluven® Important Drug Warning - June 26, 2013

---

Magnesium Sulfate Injection, USP Update - June 6, 2013

Magnesium Sulfate Injection, USP Package Insert